Megha Ranganathan

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Prevalence and clinical characterization of MMR-D/MSI extra-colonic cancers among germline PMS2 mutation carriers.”.

Prevalence and clinical characterization of MMR-D/MSI extra-colonic cancers among germline PMS2 mutation carriers.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1527

N/A

0DataRank · unranked

1 citations

Erin Salo‐Mullen, Amanda Catchings, Megha Ranganathan, Elise Fiala, Yelena Kemel +15 more

Early age of onset and broad cancer spectrum persist in MSH6 and PMS2-associated Lynch syndrome.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10516

N/A

0DataRank · unranked

0 citations

Karen A. Cadoo, Anna Maio, Zalak Patel, Yelena Kemel, Erin Salo‐Mullen +15 more

Comprehensive analysis of germline drivers in endometrial cancer

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad016

N/A

0DataRank · unranked

21 citations

Eric Rios‐Doria, Karen A. Cadoo, Amanda Catchings, Anna Maio, Yelena Kemel +37 more

Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic testing uptake

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.03.005

N/A

0DataRank · unranked

7 citations

Tiffany Sia, Christopher J. Fong, Aliya Khurram, Michele Waters, Yelena Kemel +19 more